Intravenous Levetiracetam in the Acute Management of Seizures
Intravenous Levetiracetam in the Acute Management of Seizures in Epilepsy
Prof. David C. Reutens
20 participants
Jun 1, 2008
Interventional
Conditions
Summary
To examine the effectiveness and tolerability of Intravenous Levetiracetam in the acute seizure setting
Eligibility
Inclusion Criteria1
- Epilepsy patients admitted for pre-surgical work-up at Monash Medical Centre with occurrence of acute seizures during epilepsy monitoring
Exclusion Criteria1
- Women who are pregnanat or are considering pregnancy, lactation, moderate to severe renal dysfunction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intravenous Levetiracetam will be administered in case of acute seizure (1000 mg over 5 minutes), for 1 dose only. Subjects will be observed and followed-up for the next 24 hrs following intravenous levetiracetam injection. Electroencephalographic recordings will be reviewed and subjects will be asked about adverse effects at 1, 12 and 24 hrs after intravenous administration of the agent.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000293369